AAHKS 2024: Use of Dexamethasone in Diabetic Patients Undergoing Total Joint Arthroplasty .
Use of Dexamethasone in Diabetic Patients Undergoing Total Joint Arthroplasty
Twelve studies involving diabetic patients undergoing total joint arthroplasty were included in this systematic review and meta-analysis comparing perioperative dexamethasone administration versus withholding dexamethasone. Pooled outcomes of interest included postoperative glucose levels, optimal dosing regimens, and complications such as infection. The administration of dexamethasone significantly elevated glucose levels on postoperative day 1 (POD1) but remained below the 200 mg/dL threshold, with no significant differences observed on POD2 or POD3. There was no increased risk of infection. The study concluded that dexamethasone is safe in diabetic patients, but further research is needed to optimize dosing and administration timing.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
